Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced a proposed profit distribution plan following its 2024 interim report, intending to distribute a cash dividend of RMB 4.00 for every 10 shares held. This dividend represents 25.51% of the net profit attributable to shareholders in the first half of 2024, with a total payout of RMB 650,316,379.60. The company’s financial statements for the period, which were unaudited, will be subject to approval at the 2024 general meeting.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.
